- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有26家主力机构披露2026-06-30报告期持股数据，持仓量总计4593.59万股，占流通A股33.60%
- 波段诊断：
-
技术面诊股
诊断结果：3.2技术面打败了23%的股票
技术面评分前10的股票
近期的平均成本为73.47元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为73.47元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"73.47","date":1793262016,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2026.10.30","stock":"-0.84","trade":"-1.05","ind":"-2.73"},{"date":"2026.10.29","stock":"-1.28","trade":"-1.88","ind":"-2.92"},{"date":"2026.10.28","stock":"4.37","trade":"1.46","ind":"2.02"},{"date":"2026.10.27","stock":"-5.11","trade":"-3.85","ind":"-2.50"},{"date":"2026.10.26","stock":"-3.44","trade":"0.14","ind":"-1.19"},{"date":"2026.10.23","stock":"2.54","trade":"1.64","ind":"2.79"},{"date":"2026.10.22","stock":"-5.56","trade":"-3.34","ind":"-2.96"},{"date":"2026.10.21","stock":"0.83","trade":"0.13","ind":"-0.82"},{"date":"2026.10.20","stock":"3.99","trade":"1.00","ind":"-0.14"},{"date":"2026.10.19","stock":"-4.75","trade":"-1.42","ind":"0.13"},{"date":"2026.10.16","stock":"-2.06","trade":"-0.03","ind":"-0.12"},{"date":"2026.10.15","stock":"-0.16","trade":"-1.39","ind":"-2.43"},{"date":"2026.10.14","stock":"6.57","trade":"-1.41","ind":"-1.97"},{"date":"2026.10.13","stock":"-0.53","trade":"-0.78","ind":"-0.25"},{"date":"2026.10.12","stock":"-5.27","trade":"-2.33","ind":"-2.03"},{"date":"2026.10.09","stock":"1.86","trade":"1.57","ind":"0.17"},{"date":"2026.10.08","stock":"-4.42","trade":"-1.77","ind":"-2.07"},{"date":"2026.09.30","stock":"1.09","trade":"2.11","ind":"-0.11"},{"date":"2026.09.29","stock":"-0.93","trade":"0.13","ind":"0.34"},{"date":"2026.09.28","stock":"-1.32","trade":"-0.49","ind":"-3.44"},{"date":"2026.09.24","stock":"-2.76","trade":"-2.45","ind":"-2.34"}]
广生堂,深证成指,化学制药指数
压力支撑
该股压力位为73.30元，支撑位为71.17元。
[{"text":"\u538b\u529b\u4f4d","value":"73.30","date":1793289600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"71.17","date":1793289600,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.6资金面打败了21%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月30日 20:30
| 机构今日流向(万元) | 207.68 | 机构5日流向(万元) | -2738.72 |
| 机构10日流向(万元) | -5263.44 | 机构20日流向(万元) | -11615.65 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少561.87万股，其中基金净减仓5家，主力净减仓40家，请投资者中长期谨慎为宜。
截止2026-06-30，共26家主力机构（一般法人4家，基金21家，基本养老保险基金1家），持仓量总计4593.59万股，占流通A股33.60%
其中，基金持仓与2025-12-31相比：
增仓：3家 ，增持 0.83万股
减仓：8家 ，减持 27.28万股
新出现在主力名单中：10家 ，持有1.72万股
从主力名单中消失：50家 ，原持有475.3万股
其中，基金持仓与2025-12-31相比：
增仓：3家 ，增持 0.83万股
减仓：8家 ，减持 27.28万股
新出现在主力名单中：10家 ，持有1.72万股
从主力名单中消失：50家 ，原持有475.3万股
消息面诊股
诊断结果：5.6消息面打败了33%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 广生堂：10月29日获融资买入901.62万元
2026-10-30 - 广生堂：10月28日获融资买入1688.24万元
2026-10-29 - 广生堂前三季度净利润约-1.04亿元，同比减亏
2026-10-28 - 广生堂前三季度研发投入同比增长138% 乙肝创新药
2026-10-28 - 广生堂：10月27日获融资买入1334.32万元
2026-10-28 - 股东追踪|宋外国等新进广生堂前十大流通股东
2026-10-28 - 广生堂：2026年第三季度净利润亏损3541.82
2026-10-27 - 广生堂：10月26日获融资买入1029.63万元
2026-10-27 - 广生堂：10月23日获融资买入977.38万元
2026-10-26 - 广生堂药业精彩亮相2026年中华医学会肝病学分会学
2026-10-25
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2026-10-16 |
| 一般消息 | 重大事项 | 关联交易 | 2026-10-16 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-09-18 |
| 一般消息 | 募资投向 | 2026-09-17 | |
| 一般消息 | 重大事项 | 关联交易 | 2026-09-15 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-09-12 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-09-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-08-29 |
| 利好 | 股票增发 | 已实施 | 2026-08-12 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-07-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-29 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-04-29 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-01-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-21 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：2.5行业面打败了43%的股票
化学制药行业最新资金流向
近10日来该行业走势总体向下，接近大盘。
行业走势
近10日来该行业走势总体向下，接近大盘。
[{"date":"2026.10.30","price":"-2.73","value":"-1.05"},{"date":"2026.10.29","price":"-2.92","value":"-1.88"},{"date":"2026.10.28","price":"2.02","value":"1.46"},{"date":"2026.10.27","price":"-2.50","value":"-3.85"},{"date":"2026.10.26","price":"-1.19","value":"0.14"},{"date":"2026.10.23","price":"2.79","value":"1.64"},{"date":"2026.10.22","price":"-2.96","value":"-3.34"},{"date":"2026.10.21","price":"-0.82","value":"0.13"},{"date":"2026.10.20","price":"-0.14","value":"1.00"},{"date":"2026.10.19","price":"0.13","value":"-1.42"},{"date":"2026.10.16","price":"-0.12","value":"-0.03"},{"date":"2026.10.15","price":"-2.43","value":"-1.39"},{"date":"2026.10.14","price":"-1.97","value":"-1.41"},{"date":"2026.10.13","price":"-0.25","value":"-0.78"},{"date":"2026.10.12","price":"-2.03","value":"-2.33"},{"date":"2026.10.09","price":"0.17","value":"1.57"},{"date":"2026.10.08","price":"-2.07","value":"-1.77"},{"date":"2026.09.30","price":"-0.11","value":"2.11"},{"date":"2026.09.29","price":"0.34","value":"0.13"},{"date":"2026.09.28","price":"-3.44","value":"-0.49"},{"date":"2026.09.24","price":"-2.34","value":"-2.45"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 莱美药业 | 82.20% | 26.98% | 6.1分 |
| 2 | 健康元 | 17.68% | 8.41% | 6.6分 |
| 3 | 海正药业 | 13.30% | -8.16% | 6.2分 |
| 4 | 恒瑞医药 | 8.02% | 3.06% | 6.5分 |
| 5 | 丽珠集团 | 7.38% | 5.75% | 5.5分 |
| 6 | 健友股份 | 4.94% | -0.86% | 6.1分 |
| 8 | 向日葵 | 4.70% | -6.87% | 4.5分 |
| 10 | 仙琚制药 | 3.25% | 1.25% | 6.4分 |
| 12 | 海欣股份 | 2.47% | -10.06% | 4.8分 |
| 14 | 华东医药 | 2.15% | 0.91% | 6.2分 |
| 16 | 百利天恒 | 1.99% | -8.76% | 5.7分 |
| 18 | 华邦健康 | 1.63% | 3.80% | 5.5分 |
| 20 | 京新药业 | 0.00% | -0.79% | 6.0分 |
| 22 | 新和成 | -0.39% | -0.58% | 6.0分 |
| 24 | 复星医药 | -0.79% | -2.24% | 5.4分 |
| 26 | 迪哲医药 | -1.20% | -11.95% | 5.5分 |
| 28 | - | -1.82% | -1.45% | 分 |
| 30 | 威尔药业 | -1.91% | -0.15% | 5.1分 |
| 32 | 百济神州 | -3.40% | -10.29% | 5.1分 |
| 34 | 华润双鹤 | -4.11% | -3.81% | 5.7分 |
| 36 | 吉贝尔 | -4.52% | -1.43% | 5.0分 |
| 38 | 海翔药业 | -4.81% | -5.14% | 4.6分 |
| 40 | 卫信康 | -5.42% | -2.45% | 5.5分 |
| 42 | - | -5.75% | -4.64% | 分 |
| 44 | 九典制药 | -6.13% | -4.08% | 5.1分 |
| 46 | 司太立 | -6.26% | -0.63% | 4.7分 |
| 48 | 兴齐眼药 | -6.44% | -3.62% | 5.3分 |
| 50 | 昂利康 | -6.79% | -11.07% | 4.5分 |
| 52 | 天宇股份 | -7.28% | -1.64% | 4.6分 |
| 54 | ST诺泰 | -7.32% | -2.27% | 4.1分 |
| 56 | 奥赛康 | -7.54% | -3.72% | 4.6分 |
| 58 | - | -7.68% | -4.59% | 分 |
| 60 | 东北制药 | -7.86% | -3.34% | 4.6分 |
| 62 | 金陵药业 | -8.10% | -5.30% | 4.2分 |
| 64 | 通化金马 | -9.22% | -8.49% | 4.9分 |
| 66 | 力生制药 | -9.33% | -4.86% | 3.9分 |
| 68 | 鲁抗医药 | -9.68% | -7.35% | 4.2分 |
| 70 | 川宁生物 | -9.85% | -3.60% | 4.3分 |
| 72 | ST天圣 | -10.10% | -3.44% | 4.2分 |
| 74 | 海思科 | -10.59% | -9.31% | 6.2分 |
| 76 | 尔康制药 | -10.66% | -1.72% | 4.4分 |
| 78 | ST南新 | -11.11% | -2.70% | 3.6分 |
| 80 | 双鹭药业 | -11.86% | -5.50% | 3.9分 |
| 82 | 莎普爱思 | -12.14% | -9.19% | 4.5分 |
| 84 | 立方制药 | -12.89% | -6.57% | 5.1分 |
| 86 | 上海谊众 | -13.14% | -7.81% | 4.9分 |
| 88 | 新天地 | -13.57% | -7.33% | 4.2分 |
| 90 | 宏源药业 | -13.75% | -4.69% | 4.5分 |
| 92 | 康芝药业 | -13.97% | -6.85% | 4.6分 |
| 94 | 首药控股 | -14.10% | -9.37% | 5.4分 |
| 96 | 民生健康 | -14.21% | -2.00% | 4.5分 |
| 98 | 博瑞医药 | -14.31% | -6.13% | 4.9分 |
| 100 | 广生堂 | -14.45% | -6.38% | 3.8分 |
| 102 | 凯因科技 | -15.09% | -5.88% | 4.2分 |
| 104 | 亚太药业 | -15.62% | -9.62% | 4.0分 |
| 106 | 金城医药 | -15.72% | -8.15% | 4.7分 |
| 108 | 汉商集团 | -16.10% | -11.39% | 5.1分 |
| 110 | 富士莱 | -16.49% | -8.39% | 4.2分 |
| 112 | 海南海药 | -16.63% | -6.68% | 3.8分 |
| 114 | 仟源医药 | -16.72% | -9.12% | 4.7分 |
| 116 | 国邦医药 | -16.91% | -2.02% | 5.2分 |
| 118 | 津药药业 | -17.02% | -8.51% | 4.5分 |
| 120 | 盟科药业 | -17.41% | -3.39% | 4.5分 |
| 122 | 常山药业 | -17.44% | -2.45% | 4.7分 |
| 124 | 西点药业 | -17.52% | -10.61% | 4.8分 |
| 126 | 苑东生物 | -17.90% | -11.30% | 4.9分 |
| 128 | 北陆药业 | -17.99% | -0.25% | 4.8分 |
| 130 | 东亚药业 | -18.41% | -7.21% | 4.2分 |
| 132 | 华纳药厂 | -18.78% | -9.06% | 4.3分 |
| 134 | 键凯科技 | -18.98% | -4.36% | 4.6分 |
| 136 | 悦康药业 | -19.21% | -15.82% | 3.9分 |
| 138 | 微芯生物 | -21.66% | -12.43% | 4.6分 |
| 140 | 美诺华 | -21.90% | -2.79% | 4.3分 |
| 142 | 艾力斯 | -22.28% | -8.08% | 5.4分 |
| 144 | 科源制药 | -23.66% | -5.99% | 4.8分 |
| 146 | 神奇制药 | -23.76% | -5.98% | 4.5分 |
| 148 | - | -24.07% | -5.23% | 分 |
| 150 | 亚虹医药 | -25.73% | -9.06% | 3.8分 |
| 152 | 华仁药业 | -26.38% | -7.64% | 4.4分 |
| 154 | 宏辉果蔬 | -28.35% | -14.09% | 4.1分 |
| 156 | 赛分科技 | -30.65% | 0.54% | 5.5分 |
| 158 | 哈药股份 | -31.82% | -0.18% | 4.7分 |
| 160 | 益方生物 | -33.92% | -18.11% | 4.4分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 129/218 ， 37/218。
[{"date":"2026-09-30","value":"-18.89","vol":"-5.19"},{"date":"2026-06-30","value":"-27.99","vol":"-0.06"},{"date":"2026-03-31","value":"-9.80","vol":"0.46"},{"date":"2025-12-31","value":"-68.32","vol":"-1.74"},{"date":"2025-09-30","value":"-30.03","vol":"1.57"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-18.89 | -27.99 | -9.80 | -68.32 | -30.03 |
| 行业(%) | -5.19 | -0.06 | 0.46 | -1.74 | 1.57 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"60.56","vol":"48.47"},{"date":"2026-06-30","value":"57.27","vol":"49.07"},{"date":"2026-03-31","value":"66.95","vol":"50.10"},{"date":"2025-12-31","value":"62.32","vol":"49.45"},{"date":"2025-09-30","value":"61.91","vol":"49.28"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
60.56 | 57.27 | 66.95 | 62.32 | 61.91 |
| 行业(%) | 48.47 | 49.07 | 50.10 | 49.45 | 49.28 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 57/218 ， 56/218。
[{"date":"2026-09-30","value":"4.08","vol":"38.90"},{"date":"2026-06-30","value":"5.41","vol":"19.66"},{"date":"2026-03-31","value":"0.85","vol":"23.45"},{"date":"2025-12-31","value":"-5.68","vol":"37.42"},{"date":"2025-09-30","value":"-3.21","vol":"139.36"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
4.08 | 5.41 | 0.85 | -5.68 | -3.21 |
| 行业(%) | 38.90 | 19.66 | 23.45 | 37.42 | 139.36 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"7.19","vol":"165.26"},{"date":"2026-06-30","value":"-2.18","vol":"353.66"},{"date":"2026-03-31","value":"9.00","vol":"48.30"},{"date":"2025-12-31","value":"-39.37","vol":"-23.63"},{"date":"2025-09-30","value":"-57.96","vol":"3.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
7.19 | -2.18 | 9.00 | -39.37 | -57.96 |
| 行业(%) | 165.26 | 353.66 | 48.30 | -23.63 | 3.94 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 108/218 ， 112/218。
[{"date":"2026-09-30","value":"0.19","vol":"0.31"},{"date":"2026-06-30","value":"0.16","vol":"0.21"},{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.29","vol":"0.41"},{"date":"2025-09-30","value":"0.21","vol":"0.30"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.19 | 0.16 | 0.07 | 0.29 | 0.21 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.41 | 0.30 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.01","vol":"2.01"},{"date":"2026-06-30","value":"0.74","vol":"1.30"},{"date":"2026-03-31","value":"0.26","vol":"0.65"},{"date":"2025-12-31","value":"1.31","vol":"2.59"},{"date":"2025-09-30","value":"0.93","vol":"1.94"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.01 | 0.74 | 0.26 | 1.31 | 0.93 |
| 行业(次) | 2.01 | 1.30 | 0.65 | 2.59 | 1.94 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"-35.55","vol":"0.26"},{"date":"2026-06-30","value":"-6.55","vol":"5.40"},{"date":"2026-03-31","value":"-20.41","vol":"-2.46"},{"date":"2025-12-31","value":"10.01","vol":"15.68"},{"date":"2025-09-30","value":"-24.06","vol":"4.82"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -35.55 | -6.55 | -20.41 | 10.01 | -24.06 |
| 行业 | 0.26 | 5.40 | -2.46 | 15.68 | 4.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.64","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.60","vol":"1.59"},{"date":"2025-09-30","value":"","vol":"0.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.64 | - | 0.60 | - |
| 行业 | 0.00 | 1.31 | 0.00 | 1.59 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/218 ， 66/218。
[{"date":"2026-09-30","value":"2.07","vol":"3.60"},{"date":"2026-06-30","value":"0.86","vol":"3.68"},{"date":"2026-03-31","value":"1.02","vol":"3.65"},{"date":"2025-12-31","value":"1.08","vol":"3.44"},{"date":"2025-09-30","value":"1.03","vol":"3.52"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.07 | 0.86 | 1.02 | 1.08 | 1.03 |
| 行业 | 3.60 | 3.68 | 3.65 | 3.44 | 3.52 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.67","vol":"2.91"},{"date":"2026-06-30","value":"0.46","vol":"2.98"},{"date":"2026-03-31","value":"0.61","vol":"3.01"},{"date":"2025-12-31","value":"0.64","vol":"2.82"},{"date":"2025-09-30","value":"0.62","vol":"2.78"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.67 | 0.46 | 0.61 | 0.64 | 0.62 |
| 行业 | 2.91 | 2.98 | 3.01 | 2.82 | 2.78 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 14/218 ， 15/218。
[{"date":"2026-09-30","value":"53.33","vol":"32.60"},{"date":"2026-06-30","value":"79.64","vol":"33.24"},{"date":"2026-03-31","value":"77.64","vol":"32.97"},{"date":"2025-12-31","value":"75.27","vol":"34.15"},{"date":"2025-09-30","value":"69.18","vol":"33.59"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
53.33 | 79.64 | 77.64 | 75.27 | 69.18 |
| 行业(%) | 32.60 | 33.24 | 32.97 | 34.15 | 33.59 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.31","vol":"0.67"},{"date":"2026-06-30","value":"5.09","vol":"0.70"},{"date":"2026-03-31","value":"4.36","vol":"9.64"},{"date":"2025-12-31","value":"3.80","vol":"1.73"},{"date":"2025-09-30","value":"2.74","vol":"1.17"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.31 | 5.09 | 4.36 | 3.80 | 2.74 |
| 行业(%) | 0.67 | 0.70 | 9.64 | 1.73 | 1.17 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"-1.27","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-3.49","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.56","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-2.18","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"-0.86","blueLineValue":"-0.54","type":"YC"}]